Who owns Ermium Therapeutics?

Ermium Therapeutics is currently owned by Erganeo, through Erganeo, since 2019.

When did Erganeo acquire Ermium Therapeutics?

Erganeo acquired Ermium Therapeutics in 2019 (active for 7 years).

Home/Companies/Healthcare/Ermium Therapeutics

Ermium Therapeutics

Healthcare·

France·Active·7yr hold

Ermium Therapeutics is a healthcare company, headquartered in France.

Entry

2019

Hold

7yr

Status

Active

Est. EV

–

Investor

Erganeo

Key facts

HQFrance

SectorHealthcare

CXCR4 autoimmune disease biotech founded June 2019; Erganeo joined Series A EUR 6.3M September 2019 with Domain Therapeutics Kurma and…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Erganeo

6 comparable healthcare deals from other GPs

Start free

Already a member? Sign in

Data refreshed weekly · Sourced from public filings